0001022079-17-000174.txt : 20170907 0001022079-17-000174.hdr.sgml : 20170907 20170907164046 ACCESSION NUMBER: 0001022079-17-000174 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170905 FILED AS OF DATE: 20170907 DATE AS OF CHANGE: 20170907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUSCKOWSKI STEPHEN H CENTRAL INDEX KEY: 0001142624 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 171074249 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS STREET 2: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 4 1 wf-form4_150481683383336.xml FORM 4 X0306 4 2017-09-05 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001142624 RUSCKOWSKI STEPHEN H 500 PLAZA DRIVE SECAUCUS NJ 07094 1 1 0 0 Chairman, President and CEO Common Stock 2017-09-05 4 M 0 2525 58.175 A 168413 D Common Stock 2017-09-05 4 S 0 2525 108.027 D 166116 D Stock Options (Right to Buy) 58.175 2017-09-05 4 M 0 2525 58.175 D 2022-05-01 Common Stock 2525.0 166075 D This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017. This transaction was executed in multiple trades at prices ranging from $108.00 to $108.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. The options vested in three annual installments beginning with the first on May 1, 2013, the second on May 1, 2014 and the final on May 1, 2015. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Stephen H. Rusckowski 2017-09-07